BioSpace News Archive

Business

BeiGene and DualityBio Announce Partnership to Advance Differentiated Antibody Drug Conjugate (ADC) Therapy for Solid Tumors

BeiGene and DualityBio today announced an agreement for BeiGene to acquire an exclusive option for a global clinical and commercial license to an investigational, preclinical ADC therapy for patients with select solid tumors.

July 10, 2023
·
5 min read
Business

Switch Therapeutics Appoints Douglas Fambrough, Ph.D., to Board of Directors

Switch Therapeutics today announced the appointment of Douglas Fambrough, Ph.D., as an independent director to its Board.

July 10, 2023
·
3 min read
Drug Development

First Patient Enrolled in Phase 1/2 “ELUCIDATE” Trial Assessing GTAEXS617 in Advanced Solid Tumours

Exscientia plc (Nasdaq: EXAI) today announced that it has enrolled the first patient in its Phase 1/2 “ELUCIDATE” (GTAEXS617-001) study evaluating GTAEXS617 (‘617), Exscientia’s precision-designed CDK7 inhibitor, for the treatment of advanced solid tumours.

July 10, 2023
·
6 min read
Bruker Enables Advanced Life-Science and Green-Tech Research in the UK

At the EUROMAR Conference 2023 in Scotland, Bruker showcases the latest innovations in magnetic resonance technology for life science and materials science research.

July 10, 2023
·
6 min read
FDA

US FDA approves expanded indication for Novartis Leqvio® (inclisiran) to include treatment of adults with high LDL-C and who are at increased risk of heart disease

Novartis announced today that the US Food and Drug Administration (FDA) has approved a label update for Leqvio® (inclisiran) to enable earlier use in patients with elevated LDL-C who have an increased risk of heart disease, as an adjunct to diet and statin therapy1.

July 10, 2023
·
10 min read
Pharm Country

Eli Lilly Selects ABEC for World’s Largest Single-Use Biopharmaceutical Manufacturing Facility

ABEC, a leader in engineered solutions and services for biotech manufacturing, announced it will deliver multiple Custom Single Run (CSR ® ) single-use systems to Eli Lilly’s next-generation biopharmaceutical manufacturing facility in Limerick, Ireland.

July 10, 2023
·
2 min read
Business

Syneos Health Appoints Hillary Bochniak as Chief Human Resources Officer

Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, announced the appointment of Hillary Bochniak as Chief Human Resources Officer, effective July 10, 2023.

July 10, 2023
·
2 min read
Deals

Evelo Biosciences Announces $25.5 Million Private Placement

Evelo Biosciences, Inc. today announced that it has entered into a securities purchase agreement with investors in a private placement to sell 11,025,334 shares of its common stock (the “Shares”) at a purchase price of $2.31 per share.

July 10, 2023
·
2 min read
Genetown

Sumitomo Pharma America Launches as New Combined Organization with Expanded Scale, Resources & Capabilities

Sumitomo Pharma America, Inc., as previously announced on April 3, 2023, is pleased to share it has successfully launched its operations in the U.S. and related markets.

July 10, 2023
·
6 min read
ZyVersa Therapeutics Announces Publication in the Journal Circulation That Demonstrates the Role of Inflammasome Activation in Hypertrophic Heart Disease Induced by Mechanical Stress

ZyVersa Therapeutics, Inc. announces publication of an article in the peer-reviewed journal Circulation demonstrating the role of inflammasome NLRP3 activation in hypertrophic heart disease induced by mechanical stress.

July 10, 2023
·
6 min read